Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04915898 · ClinicalTrials.gov registry record · NA
Hospital-acquired Pneumonia Prevention: Intervention, Evaluation & Research
A NA study, sponsored by Orlando Health.
- Completed
- Registry status
- NA
- Development phase
- 8,709
- Enrollment target
NCT04915898: Completed NA study, sponsored by Orlando Health.
NCT04915898 is a NA study that has completed, run by Orlando Health. The registered enrollment target is 8,709 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (521% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04915898, a NA study, has completed, sponsored by Orlando Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 8,709 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of a universal, standardized oral care protocol on prevention of non-ventilated hospital-acquired pneumonia (NV-HAP) in the acute care setting. In the course of the year-long study, the research team will provide educational and materials support for oral hygiene on two interventional units (one medical; one surgical) and two control units (one matched medical; one surgical). At the end of the study, the research team will evaluate existing hospital data to determine the number of NV-HAPs in the interventional and control groups.
Primary Outcome
Percent reduction of hospital acquired pneumonia
Interventions
- OTHER Oral Hygiene - teeth brushing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,709 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2020-04-30 |
| Phase | NA |
What the finished NCT04915898 record still lists
NCT04915898 is an interventional study that assigns participants to a tested intervention. Its 8,709 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (521% higher).
The record links to 0 conditions, and to 1 intervention - of which Oral Hygiene - teeth brushing is the first listed.
NCT04915898 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04915898 about?
NCT04915898 is a clinical study titled "Hospital-acquired Pneumonia Prevention: Intervention, Evaluation & Research". The purpose of this study is to determine the effectiveness of a universal, standardized oral care protocol on prevention of non-ventilated hospital-acquired pneumonia (NV-HAP) in the acute care setting. In the course of the year-long study, the research team will provide educational and materials s...
What is the current status of trial NCT04915898?
This trial is currently completed. It is a NA study. The enrollment target is 8,709 participants. The study started on 2018-10-01. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT04915898?
The interventions under investigation include: Oral Hygiene - teeth brushing (OTHER).
Who is sponsoring clinical trial NCT04915898?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04915898's enrollment target sits among peer trials
8,709 18th of 2000 higher than 1,983 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI